Neuberger Berman Group
TWST icon

Neuberger Berman Group’s Twist Bioscience TWST Stock Holding History

Neuberger Berman Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.15M Sell
108,300
-27,322
-20% -$1.22M ﹤0.01% 975
2025
Q4 		$4.3M Sell
135,622
-25,552
-16% -$797K ﹤0.01% 1009
2025
Q3 		$4.54M Buy
161,174
+40,755
+34% +$1.23M ﹤0.01% 986
2025
Q2 		$4.43M Buy
120,419
+111,621
+1,269% +$3.86M ﹤0.01% 999
2025
Q1 		$345K Buy
8,798
+49
+0.6% +$2.21K ﹤0.01% 1654
2024
Q4 		$407K Hold
8,749
– – ﹤0.01% 1576
2024
Q3 		$395K Sell
8,749
-203
-2% -$9.66K ﹤0.01% 1587
2024
Q2 		$441K Buy
+8,952
New +$365K ﹤0.01% 1525
2022
Q4 		– Sell
-6,474
Closed -$228K – 1874
2022
Q3 		$228K Buy
6,474
+36
+0.6% +$1.53K ﹤0.01% 1696
2022
Q2 		$225K Buy
+6,438
New +$228K ﹤0.01% 1725
2022
Q1 		– Sell
-63,802
Closed -$4.87M – 1982
2021
Q4 		$4.87M Buy
63,802
+38,195
+149% +$3.92M ﹤0.01% 987
2021
Q3 		$2.7M Buy
+25,607
New +$2.93M ﹤0.01% 1105

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neuberger Berman Group's TWST Position: Q1 2026 in Review

Neuberger Berman Group reduced its Twist Bioscience (TWST) stake by 20% in Q1 2026, selling an estimated $1.22M and leaving 108,300 shares worth $5.15M. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Neuberger Berman Group first reported a position in TWST in Q3 2021 and has held it in 12 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Neuberger Berman Group held 108,300 shares of Twist Bioscience worth $5.15M as of Q1 2026.
  • Neuberger Berman Group sold 27,322 Twist Bioscience shares in Q1 2026, an estimated $1.22M.
  • Twist Bioscience made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #975 holding.
  • Neuberger Berman Group first reported a position in Twist Bioscience in Q3 2021 and has held it in 12 quarters since.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.